Back

Limitations of subgroup analysis of underpowered clinical trials for making causal inference about treatment effects

European Heart Journal

7 May 2020
Organised by: Logo
Read full article
ESC Journals VALVULAR, MYOCARDIAL, PERICARDIAL, PULMONARY, CONGENITAL HEART DISEASE Valvular Heart Disease

Contributors

Milad Nazarzadeh
Milad Nazarzadeh

Author

University of Oxford Oxford , United Kingdom of Great Britain & Northern Ireland

Kazem Rahimi
Kazem Rahimi

Author

University of Oxford Oxford , United Kingdom of Great Britain & Northern Ireland

You may be interested in
thumbnail
Congress Presentation
Interpreting subgroup analyses: principles and pitfalls
9 May 2026
thumbnail
Congress Session
HFA clinical trial course in a nutshell
17 May 2025
thumbnail
Congress Presentation
Risks and benefits of antiplatelet therapy in patients with abdominal aortic aneurysm without symptomatic atherosclerotic disease: a nationwide cohort study
27 August 2023
thumbnail
Congress Presentation
Effect of four hemoglobin transfusion threshold strategies in patients with acute myocardial infarction and anemia: a target trial emulation using MINT trial data
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources